Jonathan R. Day, MD, PharmD, and Brian K. Link, MD, give their perspective on emerging treatments for follicular lymphoma.
Jonathan R. Day, MD, PharmD
Advertisement
Articles by Jonathan R. Day, MD, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Anticipated Data and Practice-Changing Trials: An ASCO 2026 Breast Cancer Preview
2
FDA Approves Pivekimab Sunirine in Rare Hematologic Malignancy
3
Ciltacabtagene Autoleucel in High-Risk Smoldering Multiple Myeloma: The CAR-PRISM Phase 2 Trial
4
Toripalimab Regimen Improves EFS, MPR Rate in Stage II/III NSCLC Trial
5